$19.02
-0.000500.00%
Pre-Market: Dec 20, 4:30 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Cartesian Therapeutics in recent months.
Browse guidance and forecast on all stocks.